baber/WOPTO huggingface dataset:
Patent AU-2021260959-A1 (AU)
Title: Floor cleaner with full tank indicator
Inventor: RUKAVINA DOUGLAS M
IPC: A47L7/00
Filed: 2021-04-22
Abstract: A floor cleaner includes a recovery tank including an inflow path allowing liquid-laden air to enter the recovery tank, an outflow path allowing air to exit the recovery tank; and a chamber for storing liquid. The chamber includes an inlet, a separator that separates liquid from the liquid-laden air, an air outlet, and a float. The float includes a base and a valve with an indicator. The float is moveable between a first position and a second position. In the first position the valve is spaced away from the air outlet and air is allowed to exit the chamber. In the second position the valve is adjacent the outlet and impedes air from exiting the chamber. In the second position the indicator is visible when the chamber is full.
Patent AU-2021268725-A1 (AU)
Title: A process and apparatus for producing aqueous compositions of water-soluble polymers
Inventor: LOESCH DENNIS
IPC: C08F6/06
Filed: 2021-04-26
Abstract: Process for producing aqueous compositions of water-soluble polymers from aqueous polymer gels by comminuting and mixing the aqueous polymer gel with an aqueous liquid by means of a comminution unit comprising a flow-chamber, a sheet-like molding tool and rotating cutting means, wherein a stream of an aqueous liquid flows through the flow chamber, aqueous polymer gel is pressed through the sheet-like molding tool, cutting the thus formed gel strands into slices, dispersing them in the aqueous liquid and homogenizing the thus obtained mixture.
Patent AU-2021276000-A1 (AU)
Title: Compositions and devices for vaccine release and uses thereof
Inventor: SCHRADER MICHAEL
IPC: C12N15/86
Filed: 2021-05-21
Abstract: Microneedle and microneedle devices including implantable tips (e.g., silk-based tips) for sustained dermal delivery of a coronavirus and/or influenza vaccine, kits, as well as methods of manufacturing and using the same are described herein. In other embodiments, compositions and methods for controlled- or sustained-administration of a coronavirus vaccine and/or an influenza vaccine to provide improved immunogenicity and/or broad-spectrum immunity to a subject are also described.
Patent AU-2021283263-A1 (AU)
Title: Signaling of general constrain information
Inventor: WANG YE-KUI
IPC: H04N19/187
Filed: 2021-06-02
Abstract: Methods, systems and devices for signaling of general constraint information are described. An example method of video processing includes performing a conversion between a video comprising one or more pictures and a bitstream of the video according to a rule, wherein the rule specifies that a syntax structure in a profile-tier-level syntax structure is after a syntax element, wherein the syntax structure comprises information related to general constraint information (GCI) for the bitstream, and wherein the syntax element indicates a level to which an output layer set associated with the profile-tier-level syntax structure conforms.
Patent AU-2021292215-A1 (AU)
Title: Diffractive optic reflex sight
Inventor: PARKER WILLIAM P
IPC: G02B27/42
Filed: 2021-06-16
Abstract: A diffractive optic reflex sight (DORS) is provided for aiming devices in which a virtual image, such as a reticle, is produced and appears in the distance of a user's view when looking through the retlex sight. A light source illuminates a diffractive optical element (DOE) that includes a modulation pattern that generates a patterned illuminations corresponding with the virtual image. A reflective image combiner then reflects the patterned illumination so that the virtual image appears in the distance of the viewer's view. The DORS optical design system is mechanically and optically stable for precision aiming across a range of environmental conditions and in different use scenarios or applications including use in rapidly changing temperatures, varying light conditions, and a wide range of user proficiencies. The DORS optical design system is a readily manufacturable aiming and sighting device for a wide range of applications from handguns to astronomical telescopes.
Patent AU-2021296168-A1 (AU)
Title: LAIR-1-binding agents and methods of use thereof
Inventor: CRAWLEY SUZANNE CHRISTINE
IPC: C07K16/28
Filed: 2021-06-21
Abstract: The present disclosure provides binding agents, such as antibodies, that specifically bind LAIR-1, including human LAIR-1, as well as compositions comprising the binding agents, and methods of their use. The disclosure also provides related polynucleotides and vectors encoding the binding agents and cells comprising the binding agents.
Patent AU-2021308651-A1 (AU)
Title: Flow density fluid displacement to store or generate power
Inventor: NOVEK ETHAN J
IPC: F03B13/06
Filed: 2021-07-16
Abstract: The system pertains to a first storage reservoir near the surface of a body of water and configured to store a first fluid. A second storage reservoir is located below the surface of the body of water and configured to store a second fluid which has a higher density than the first fluid. A pump, generator, and the first and second reservoir are operatively connected such that power is stored by displacing the higher density fluid in the second storage reservoir by pumping the lower density fluid in the first storage reservoir to the second storage reservoir. Power is generated or discharged by allowing the fluid which has a lower density in the second storage reservoir to return to the first storage reservoir. The higher density fluid may be in a liquid or solid-liquid mixture form. The lower density fluid may be in a liquid or solid-liquid mixture form.
Patent AU-2021321561-A1 (AU)
Title: An improved highly efficient process for the prepration of nintedanib and pharmaceutically acceptable salt thereof
Inventor: DHARMESH MAHENDRABHAI SHAH
IPC: C07D209/34
Filed: 2021-08-06
Abstract: The present invention relates to an improved highly efficient and economic process for large-scale production of Nintedanib and pharmaceutically acceptable salt thereof. The present invention also relates to a single step process that form highly pure Nintedanib through novel intermediates. In this process, Nintedanib base [I] is prepared in a single step, in-situ process wherein the process is performed by formation of two novel intermediates namely, methyl-1-(bromoacetyl)-2-oxo-2,3-dihydro-1H-indole-6-carboxylate and methyl-(3Z)-1-(bromoacetyl)-3-[methoxy(phenyl)methylidene]-2-oxo-2,3-dihydro-1H-indole-6-carboxylate. This process avoids use of expensive and hazardous reagent and solvent such as methyl cyclohexane. Further, there is no isolation and analysis of any intermediate after every step completion that made the process easy to perform without much hurdles. Along with the ease of performance, present invention process also gives high-purity final product with high yield. This makes the process highly cost-effective and time-efficient.
Patent AU-2021324130-A1 (AU)
Title: System for analysis
Inventor: ADAMS CHRISTOPHER
IPC: B01L3/00
Filed: 2021-08-13
Abstract: There is provided a device for analysis of sample liquid, the device comprising a microfluidic test card, and a microfluidic chip for processing the sample liquid presented from the microfluidic test card and return processed sample fluid to the microfluidic test card. The microfluidic test card comprises a sample inlet, configured for receiving sample liquid, first and second pre-processing test reagent channels having first and second test reagent outlets, respectively, for presenting test reagent to the microfluidic chip, a pre-processing sample channel fluidically communicating with the sample inlet for receiving sample liquid therefrom, and having a sample liquid outlet for presenting the sample liquid to the microfluidic chip, first and second processed sample analysis channels for receiving processed sample liquid from the microfluidic chip, wherein the first and the second processed sample analysis channels comprising a first and second analysis zone, respectively, for analysing the processed sample liquid, and a microfluidic chip contacting zone comprising said sample liquid outlet and first and second test reagent outlets, configured for connection and fluidic communication with the microfluidic chip.
Patent AU-2021325037-A1 (AU)
Title: Dynamic socks and associated methods
Inventor: ARCIUOLO MATTHEW J
IPC: A41B11/12
Filed: 2021-08-11
Abstract: The present disclosure relates to a dynamic sock, pantyhose, athletic pants/leggings or similar clothing, designed to increase propulsion or restrict motion in human gait as would be advantageous in athletic, lifestyle, medical or similar applications. Similarly, the described invention would be advantageous in sedentary applications to restrict joint angle for various pathologies. The exemplary sock includes an integrated propulsion/tension band with increased elastic/compression/tension capability at specific parts of the foot, ankle and lower leg to increase the tension at the dorsiflexion, midstance or plantarflexion phase of the gait cycle or restrict joint excursion in medical applications to thereby increase the rate, amount and force of plantarflexion or dorsiflexion or restrict motion in the sagittal, transverse or horizontal planes.
Patent AU-2021361060-A1 (AU)
Title: Piperidinyl small molecule degraders of helios and methods of use
Inventor: LIU HU
IPC: A61K31/553
Filed: 2021-10-15
Abstract: Disclosed are compounds and pharmaceutically acceptable salts, hydrates, solvates, prodrugs, stereoisomers, or tautomers thereof that may cause degradation of various proteins e.g., IKZF2 (Helios). Also disclosed are pharmaceutical compositions containing same, and methods of making and using the compounds to treat diseases and disorders associated with Helios and which may benefit from Helios degradation.
Patent AU-2021370954-A1 (AU)
Title: Methods for processing fetal support tissue
Inventor: TSENG SCHEFFER
IPC: A61K35/50
Filed: 2021-10-25
Abstract: Disclosed herein, in certain embodiments are methods of preparing a fetal support tissue product comprising: cryopulverizing or homogenizing a fetal support tissue, extracting the cryopulverized fetal support tissue in an excipient, and sterilizing the extract. Also disclosed herein are pharmaceutical compositions comprising said fetal support tissue product and methods of using said fetal support tissue product for treating wounds, spinal conditions, and arthritis.
Patent AU-2021377176-A1 (AU)
Title: Bifunctional antagonists of activin/tgf-beta and rankl and uses thereof
Inventor: HAN HQ
IPC: A61P35/00
Filed: 2021-11-05
Abstract: This invention disclosure provides novel bifunctional molecules comprising at least one RANKL binding molecule and at least one Activin or TGF-β binding molecule, which are capable of sequestering RANKL and Activin or TGF-β in parallel. Also provided are pharmaceutical compositions of such bifunctional antagonist molecules and their therapeutic uses to treat various bone disorders whose pathogenesis involves the activation of both RANKL-NFKB and Αctivin/TGF-β-Smad2/3 signaling pathways, such as bone metastasis, bone loss in cancer, bone fragility in neuromuscular diseases, osteogenesis imperfecta, fracture, osteopenia and osteoporosis.
Patent AU-2021406544-A1 (AU)
Title: Haircare appliance
Inventor: PEEL AYRTON
IPC: A45D20/12
Filed: 2021-12-16
Abstract: Disclosed is an attachment (100, 200, 300, 400, 500, 600) for a haircare appliance (10), the attachment (100, 200, 300, 400, 500, 600) comprising: an air inlet (101) for receiving an airflow; an air outlet (102) for emitting the airflow; and a hair treatment chamber (103) for receiving hair, the hair treatment chamber (103) in fluid communication with the air outlet (102); wherein the hair treatment chamber (103) comprises a wall (104), an opening (105) through which hair is insertable into the hair treatment chamber (103), and an aperture (106) formed in the wall (104), the air outlet (102) configured to direct airflow away from the opening (105) and toward the aperture (105) in use.
Patent AU-2022200403-A1 (AU)
Title: Heart valve prosthesis and delivery
Inventor: WALSH BRANDON G
IPC: A61F2/24
Filed: 2022-01-21
Abstract: Document-2I/01/2022 
ABSTRACT 
The present disclosure relates to a valve delivery device comprising: distal assembly 
comprising: a core member extending along a longitudinal axis of the assembly; a distal 
carrier assembly comprising a distal enclosure and a proximal enclosure, the distal enclosure 
being coupled to the core member and configured to cover a distal portion of a valve frame 
of a valve prosthesis, the proximal enclosure being slidably coupled to the core member and 
configured to cover a proximal portion of the valve frame, wherein the proximal enclosure 
is separable relative to the distal enclosure; a proximal sheath, proximal to the distal carrier 
assembly, extending along the core member and configured to cover at least a portion of a 
valve anchor of the valve prosthesis; and a control unit comprising a control handle, coupled 
to the core member, and configured to control an operation of the distal assembly, the control 
unit further comprising: a first control element coupled to the control handle and configured 
to deflect the distal carrier assembly for steering the delivery device during advancement 
into a body lumen; a second control element coupled to the control handle and configured 
to actuate the proximal sheath for proximally retracting the proximal sheath relative to the 
distal carrier assembly and the valve anchor for exposing the valve anchor; and a third 
control element coupled to the control handle and configured to actuate a grasper mechanism 
for longitudinally moving the valve anchor relative to the core member and for controlling 
engagement with the valve anchor and the distal carrier assembly for permitting expansion 
of the valve frame.
Patent AU-2022209286-A1 (AU)
Title: Methods for predicting the usefulness of proteins or protein fragments for immunotherapy
Inventor: VORMEHR MATHIAS
IPC: G01N33/50
Filed: 2022-07-27
Abstract: The present invention relates to methods for predicting peptides or polypeptides such as T cell 
epitopes useful for immunotherapy such as for vaccination. In particular, the present invention 
relates to methods for predicting whether peptides or polypeptides such as tumor-associated 
antigens or epitopes, in particular tumor-associated neoantigens or neoepitopes, are 
immunogenic and, in particular, useful for immunotherapy such as for vaccination. The 
methods of the invention may be used, in particular, for the provision of vaccines which are 
specific for a patient's tumor and, thus, in the context of personalized cancer vaccines.
Patent AU-2022213198-A1 (AU)
Title: Method of operating an electrolyzer system and electrolyzer system
Inventor: DOLL MICHAEL
IPC: C25B1/04
Filed: 2022-01-26
Abstract: The invention relates to a method of operating an electrolyzer system, comprising an alkali lye circulating in the system, whereby a lye-related property is determined and further process control is subject to possible change in dependency of an evaluation of the determined property, wherein the property comprises the lye concentration which is in particular automatically detected and a lye refilling operation is in particular effected automatically in dependency of the detected concentration, and/or wherein the property comprises one or more visually inspectable parameter of the lye and/or lye flow, which is/are, in particular automatically and in particular during operation of the electrolyzer, detected by visual inspection of the lye/lye flow and wherein an operation condition of the electrolyzer system is determined on the basis of said evaluation.
Patent AU-2022215025-A1 (AU)
Title: Crystalline form of a piperazinyl-thiazole derivative
Inventor: FOSSHAG DOMINIK
IPC: A61P29/00
Filed: 2022-01-26
Abstract: The invention relates to a crystalline form of 1-{(R)-2-(2-Hydroxy-ethyl)-4-[2-trifluoromethyl-4-(2-trifluoromethyl-pyrimidin-5-yl)-thiazol-5-yl]-piperazin-1-yl}-2-(3-methyl-[1,2,4]triazol-1-yl)-ethanone, processes for the preparation thereof, pharmaceutical compositions comprising said crystalline form, pharmaceutical compositions prepared from such crystalline forms, and their use as CXCR3 receptor modulators in the treatment of various diseases and disorders related to the CXCR3 receptor and its ligands.
Patent AU-2022249152-A1 (AU)
Title: Pd-l1 as a predictive marker for therapy in cancer
Inventor: TULLBERG AXEL EMANUEL STENMARK
IPC: G01N33/574
Filed: 2022-03-31
Abstract: Methods for treating and/or prognosing breast cancer and breast cancer recurrence are provided. The method includes obtaining a tissue sample of a tumor from a breast cancer patient, determining an expression level of one or more markers (for example PD-1 and/or PDL1) in the sample, and providing intensified treatment to the subject based on the level of (for example) PD-1 and/or PD-L1. The intensified treatment can be intensified radiotherapy treatment.
Patent AU-2022266557-A1 (AU)
Title: Generating customized products in collaboration with live designers and agents
Inventor: BEAVER III ROBERT I
IPC: G06Q10/10
Filed: 2022-03-14
Abstract: In some embodiments, a method for generating customized products in collaboration with live designers is disclosed. The method comprises: receiving, at a computer collaboration computer, a request, from a first user interface that executes on a first user device associated with a first user, for assistance in collaborating on an interactive design; wherein the request comprises collaboration parameters; in response to receiving the request, automatically determining one or more designer profiles, each designer profile satisfying one or more of the collaboration parameters; in response to selecting a particular designer profile from the one or more designer profiles: automatically enabling a collaboration on the interactive design between the first user and a second user who has the particular designer profile; wherein the collaboration between the first user and the second user comprises automatically generating and updating product description data having a plurality of key-values pairs.
Patent AU-2022315132-A1 (AU)
Title: Alpha-sheet polypeptides and their use
Inventor: DAGGETT VALERIE
IPC: A61K38/16
Filed: 2022-05-20
Abstract: Disclosed herein are -sheet polypeptide multimers, comprising two or more monomeric -sheet polypeptides that are covalently linked. In various embodiments, the multimer comprises a dimer, trimer, tetramer, pentamer, or hexamer, or wherein the multimer comprises a dimer. Also disclosed are compositions and medical devices comprising -sheets, and their use for treating and diagnosing amyloid diseases or amyloid-associated diseases.
Patent AU-2023201452-A1 (AU)
Title: Game token and method for manufacturing the same
Inventor: SHIGETA YASUSHI
IPC: G06K19/07
Filed: 2023-03-08
Abstract: ' 
A game token by which a plurality of RFID tags embedded in a plurality of the game 
tokens stacked each other can be read in a relatively stable manner is provided. A 
game token (100) is provided with a security part (50) and a receiving part (10) 
that receives the security part (50). The security part (50) has a shape with a 
diameter smaller than the diameter of the receiving part (10), a structure with a 
plurality of plastic layers laminated together, an RFID tag (42), and a visible print 
layer (201) indicating a type or ID of the game token (10). The receiving part (10) 
has a surface The surface of the receiving part (10) has a recessed portion (11) for 
receiving the security part (50), and the depth of the recessed portion (11) is 25% 
or more of the thickness of the game token (100).
Patent AU-2023201804-A1 (AU)
Title: Systems and methods for insomnia screening and management
Inventor: SHOULDICE REDMOND
IPC: A61B5/00
Filed: 2023-03-22
Abstract: A method includes receiving physiological data associated with a user during a sleep 
session. The method also includes determining a sleep-wake signal for the user during the 
sleep session based at least in part on the received physiological data. The method also includes 
determining one or more sleep-related parameters for the user during the sleep session based 
at least in part on the sleep-wake signal. The method also includes determining that the user 
experienced insomnia during the sleep session based at least in part on at least one of the one 
or more sleep-related parameters. The method also includes identifying a type for the insomnia 
experienced by the user based at least in part on the one or more sleep-related parameters.  
4811-5692-9744
Patent AU-2023204121-A1 (AU)
Title: Compositions, methods and/or kits comprising a recombinant human cd38-extracellular domain
Inventor: HALL JOHN A
IPC: C07K14/705
Filed: 2023-06-28
Abstract: A composition that binds to an anti-CD38 antibody includes a specific sequence of a recombinant soluble 
form of an extracellular domain of CD38 and/or a fragment thereof that interferes with binding activity of 
the anti-CD38 antibody. The composition can be included in a kit for bio-monitoring research and 
diagnostic assays. The composition can be used to neutralize an anti-CD38 antibody in a sample and/or 
to select a suitable red blood cell unit for a patient treated with anti-CD38 antibodies.
Patent AU-2023204640-A1 (AU)
Title: Inflatable object and valve therefor
Inventor: GAINES C LATHAM
IPC: F16K15/20
Filed: 2023-07-13
Abstract: In an aspect, an inflatable object includes an object body enclosing a chamber to receive 
air, and a valve mounted to the inflatable object body, including a valve body defining a 
passageway between the chamber and an ambient environment. The valve body has a 
5 shoulder. The valve body defines an outside end, which opens to the ambient environment, 
and an inside end, which opens into the chamber. The valve includes a one-way flap that 
is movable between an open position to permit fluid communication between the chamber 
and the ambient environment through the passageway, and a closed position. The one
way flap is biased to the closed position with a closing force selected to be overcomable to 
0 move the one-way flap to the open position by an airflow having a speed that is less than 
about 48 m/s, and which is at a pressure lower than 1 atmosphere.
Patent WO-2020186316-A1 (WO)
Inventor: PRESSYANOV DOBROMIR
IPC: G01T1/178
Filed: 2020-01-23
Abstract: The invention relates to a compensation module for sensors for the measurement of isotopes of radioactive noble gases, and in particular of the radon-222 ( 222 Rn isotope), in a gas or liquid medium, and will find application in long-term measurements of radioactive noble gases where the measurement time is significantly longer than the equilibration time in the volume of the compensation module. The compensation module is intended to compensate for the effect of temperature on the signal received from the sensors for the measurement of radioactive noble gases and, thus, to increase the accuracy of the measurement. The module M consists of a container (1) in which the sensor (2) is placed, the. walls (4) of which are made of diffusion-permeable material for the measured radioactive noble gas, and optionally, at least one wall (5) of the container is impermeable for gas. The volume of the container, the material, the thickness and the area of the permeable wall (4) are selected such that the compensated calibration factor be permanent or almost permanent. For said compensated calibration factor CCF applies equality, which is:  CCF= CF.R,  where  CF  is the calibration factor and R is the ratio of the gas concentration inside the volume of the module to its concentration outside the module.